Hepatic phaeohyphomycosis due to a novel dematiaceous fungus, Pleurostoma hongkongense sp. nov., and importance of antifungal susceptibility testing

Emerg Microbes Infect. 2021 Dec;10(1):81-96. doi: 10.1080/22221751.2020.1866955.

Abstract

Pleurostoma species are wood-inhabiting fungi and emerging opportunistic pathogens causing phaeohyphomycosis. In this study, we isolated a dematiaceous fungus, HKU44T, from the subhepatic abscess pus and drain fluids of a liver transplant recipient with post-transplant biliary and hepatico-jejunostomy bypass strictures. Histology of the abscess wall biopsy showed abundant fungal hyphae. The patient survived after a second liver transplant and antifungal therapy. On SDA, HKU44T grew initially as white powdery colonies which turned beige upon maturation. Hyphae were septate and hyaline. Phialides were monophialidic and laterally located, generally closely associated to a cluster of conidia which were usually reniform. Phylogenetic analyses showed that HKU44T is most closely related to, but distinct from, Pleurostoma ootheca and Pleurostoma repens. These suggested that HKU44T is a novel Pleurostoma species, for which the name Pleurostoma hongkongense sp. nov. is proposed. Antifungal susceptibility testing showed that Pleurostoma species possessed high MICs/MECs for fluconazole, 5-flucytosine and the echinocandins; whereas they exhibited a high strain-to-strain variability to the susceptibilities to the other triazoles. As for amphotericin B, ∼65% of the Pleurostoma strains had low MICs (≤1 µg/mL). DNA sequencing should be performed to accurately identify fungi with Pleurostoma/Phialophora-like morphologies, so is antifungal susceptibility testing for patients with Pleurostoma infections.

Keywords: Pleurostoma; Pleurostoma hongkongense; Liver; dematiaceous fungus; novel species; phaeohyphomycosis.

MeSH terms

  • Abscess / microbiology
  • Aged
  • Antifungal Agents / pharmacology*
  • Ascomycota / classification*
  • Ascomycota / genetics
  • Ascomycota / isolation & purification
  • DNA, Fungal / genetics
  • Echinocandins / pharmacology
  • Fluconazole / pharmacology
  • Flucytosine / pharmacology
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Phaeohyphomycosis / microbiology*
  • Phylogeny
  • Sequence Analysis, DNA / methods*

Substances

  • Antifungal Agents
  • DNA, Fungal
  • Echinocandins
  • Fluconazole
  • Flucytosine

Grants and funding

This work was partly supported by the Innovation and Technology Fund Midstream Research Programme for Universities (grant number MRP/026/18) of the Innovation and Technology Commission, the Government of the Hong Kong Special Administrative Region. Any opinions, findings, conclusions or recommendations expressed in this material/event (or by members of the project team) do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Innovation and Technology Commission or the Innovation and Technology Fund Research Projects Assessment Panel.